Dr Gary Newton's group develops computational tools to help cancer drug discovery efforts process the large amounts of data obtained through biomedical research.
Dr Gary Newton is a member of the Centre for Cancer Drug Discovery where he applies his medicinal chemistry experience to validate new targets and develop effective medicines for the treatment of cancer. He has worked in biotech and contract research organisations over the course of 20 years, leading teams to discover a number of pre-clinical candidates.